國家衛生研究院 NHRI:Item 3990099045/14708
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 851558      Online Users : 893
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/14708


    Title: Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies
    Authors: Shen, KY;Yang, CH;Chen, CT;Ho, HM;Chiu, FF;Huang, CY;Liao, HC;Hsu, CW;Yu, GY;Liao, CL;Chen, HW;Huang, MH;Liu, SJ
    Contributors: National Institute of Infectious Diseases and Vaccinology;Institute of Biotechnology and Pharmaceutical Research
    Abstract: The major challenge in COVID-19 vaccine effectiveness is immune escape by SARS-CoV-2 variants. To overcome this, an Omicron-specific mRNA vaccine was designed. The extracellular domain of the spike of the Omicron variant was fused with a modified GCN4 trimerization domain with low immunogenicity (TSomi). After immunization with TSomi mRNA in hamsters, animals were challenged with SARS-CoV-2 virus. The raised nonneutralizing antibodies or cytokine secretion responses can recognize both Wuhan S and Omicron S. However, the raised antibodies neutralized SARS-CoV-2 Omicron virus infection but failed to generate Wuhan virus neutralizing antibodies. Surprisingly, TSomi mRNA immunization protected animals from Wuhan virus challenge. These data indicated that nonneutralizing antibodies or cellular immunity may play a more important role in vaccine-induced protection than previously believed. Next-generation COVID-19 vaccines using the Omicron S antigen may provide sufficient protection against ancestral or current SARS-CoV-2 variants. This article is protected by copyright. All rights reserved.
    Date: 2022-12-02
    Relation: Journal of Medical Virology. 2022 Dec 2;95:Article number e28370.
    Link to: http://dx.doi.org/10.1002/jmv.28370
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0146-6615&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000911465200289
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85145921977
    Appears in Collections:[Shih-Jen Liu] Periodical Articles
    [Ming-Hsi Huang] Periodical Articles
    [Guann-Yi Yu] Periodical Articles
    [Ching-Len Liao] Periodical Articles
    [Chiung-Tong Chen] Periodical Articles
    [Hsin-Wei Chen] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    PUB36458553.pdf1597KbAdobe PDF162View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback